Michael Parry, MD
Infectious Disease · Stamford, CTNPI 1578535431
Payments from drug & device makers
What this record shows
This record is dominated by education: $100 of the $133 with a category attached, or 75.0%. Janssen Products, LP accounts for 75.0% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for infectious disease clinicians in CT, where the typical reported total is $181.
Across 2 payments — averaging $66.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Products, LP$100
- Viiv Healthcare Company$33
Across 53 payments — averaging $20,388 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.1M
What the payments were for
- Food & beverage$3325%
- Education$10075%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Products, LP | 1 | $100 |
| Viiv Healthcare Company | 1 | $33 |
How this compares
$133 in reported general payments places this provider in the 45th percentile of 159 infectious disease providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 24 | $103,000 |
| Doxycycline Hyclate | 12 | $509 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Stamford
- Gavin McLeodStamford$9K
- Zane SaulStratford$513K
- Stephen ScholandMeriden$428K
- Onyema OgbuaguNew Haven$412K
- David RubinNorwalk$397K
- Steven SchnittmanWest Haven$363K
- Kalpana GuptaWest Haven$160K
- Frederick AlticeNew Haven$143K
- Paul AnthonyHartford$91K
- Adrian DemidontHamden$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.